| Financial Year |
March 31 2023 |
| Monetary Funds |
290,668,278.39 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
13,472,669.16 |
| Advances to Suppliers |
20,002,153.01 |
| Other Receivables |
4,717,177.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,889,821,043.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
15,684,932.60 |
| Total Current Assets |
4,241,407,306.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
27,142,732.17 |
| Fixed Assetes |
985,832,168.80 |
| Under-construction Projects |
9,363,256.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
55,552,034.47 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,596,360,032.73 |
| R&D expenses |
-- |
| Goodwill |
146,927,479.72 |
| Long-Term Deferred and Prepaid Expenses |
25,807,515.43 |
| Deferred Income Tax Assets |
66,180,598.75 |
| Other Non-Current Assets |
25,761,776.04 |
| Sub-Total of Non-Current Assets |
2,956,163,241.20 |
| Total Assets |
7,197,570,547.47 |
| Short-Term Loans |
1,022,307,719.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
37,523,435.03 |
| Accounts Received In Advance |
2,194,577.21 |
| Employee Compensation Payable |
8,584,524.12 |
| Taxes Payable |
11,625,936.37 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
307,695,279.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,526,797.72 |
| Other Current Liabilities |
557,788,116.64 |
| Sub-Total of Current Liabilities |
1,967,280,129.50 |
| Long-term Loans |
505,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
21,439,130.05 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,625,943.23 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
580,797,974.71 |
| Total Liabilities |
2,548,078,104.21 |
| Paid-In Capital(Or Share Stock) |
1,344,543,367.00 |
| Capital Surplus |
1,057,642,982.69 |
| Surplus Reserve |
102,518,115.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,102,748,203.90 |
| Minority Stockholder's Interest |
42,039,774.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,607,452,668.59 |
| Owner's Equity（Stockholder's Equity） |
4,649,492,443.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,197,570,547.47 |
